DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
TACE-2.
A randomized placebo-controlled, double blinded, phase III trial of sorafenib in combination with transarterial chemoembolization in hepatocellular cancer.
Available at:
http://clinicaltrials.gov/ct2/show/NCT01324076 . Accessed February 23, 2012
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.